{
  "id": 20658271,
  "title": "Lilly Buying Spree Surpasses $32B",
  "url": "https://urgent.news/2026/11/18/lilly-buying-spree-surpasses-32b",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-18T21:11:03.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-11-18/lilly-buying-spree-surpasses-32b-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "Bloomberg’s Madison Muller joins Dani Burger on “Bloomberg Deals.” Eli Lilly agreed to buy closely held Calytrix Bio in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s $32 billion wave of acquisitions in 2026 as it builds out its cancer and immunology businesses. (Source: Bloomberg)",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}